Humana Inc. reported consolidated income before income taxes of $134 million for the third quarter of 2025, down from $651 million in the third quarter of 2024. For the nine months ended September 30, 2025, consolidated income before income taxes was $2,566 million, compared to $2,583 million for the same period in 2024. The results reflect the impact of the company's exit from the employer group commercial medical products business, as previously announced. Adjusted (non-GAAP) diluted earnings per share for full year 2025 are projected to be approximately $17.00, up from $16.21 reported for 2024. The company highlighted value creation initiatives and noted the effects of litigation settlements, business sales, and impairment charges on its financial results.